Follow
PASCUAL FERNANDEZ ABELLAN
PASCUAL FERNANDEZ ABELLAN
Profesor Asociado de Hematología. Universidad Miguel Hernández
Verified email at goumh.umh.es
Title
Cited by
Cited by
Year
Comparison of the Results of the Treatment of Adolescents and Young Adults With Standard-Risk Acute Lymphoblastic Leukemia With the Programa Espanol de Tratamiento en …
JM Ribera, A Oriol, MA Sanz, M Tormo, P Fernández-Abellán, E del Potro, ...
Journal of Clinical Oncology 26 (11), 1843-1849, 2008
3162008
Treatment of high-risk Philadelphia chromosome–negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual …
JM Ribera, A Oriol, M Morgades, P Montesinos, J Sarrà, ...
Journal of Clinical Oncology 32 (15), 1595-1604, 2014
2932014
Risk factors and outcome of COVID-19 in patients with hematological malignancies
JL Piñana, R Martino, I García-García, R Parody, MD Morales, G Benzo, ...
Experimental Hematology & Oncology 9, 1-16, 2020
1372020
Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia
CM Santamaría, MC Chillón, R García-Sanz, C Perez, MD Caballero, ...
Blood, The Journal of the American Society of Hematology 114 (1), 148-152, 2009
1312009
Autologous stem cell transplantation for primary refractory Hodgkin’s disease: results and clinical variables affecting outcome
M Constans, A Sureda, MJ Terol, R Arranz, MD Caballero, A Iriondo, ...
Annals of oncology 14 (5), 745-751, 2003
722003
High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics
CM Santamaría, MC Chillón, R García-Sanz, C Pérez, MD Caballero, ...
Leukemia research 33 (12), 1706-1709, 2009
682009
Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of …
A Oriol, JM Ribera, J Esteve, MA Sanz, S Brunet, R Garcia-Boyero, ...
haematologica 88 (4), 445-453, 2003
662003
A prognostic model for survival after salvage treatment with FLAG‐Ida+/− gemtuzumab‐ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia
JM Bergua, P Montesinos, D Martinez‐Cuadrón, P Fernández‐Abellán, ...
British Journal of Haematology 174 (5), 700-710, 2016
582016
Severe skin reaction to imatinib in a case of Philadelphia-positive acute lymphoblastic leukemia
B Sanchez-Gonzalez, JC Pascual-Ramirez, P Fernandez-Abellan, ...
Blood, The Journal of the American Society of Hematology 101 (6), 2446-2446, 2003
532003
Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia
MB Vidriales, E Pérez-López, C Pegenaute, M Castellanos, JJ Pérez, ...
Leukemia research 40, 1-9, 2016
462016
Post-transplant Burkit t's Leukemia or Lymphoma. Study of Five Cases Treated with Specific Intensive Therapy (PETHEMA ALL-3/97 Trial)
B Xicoy, JM Ribera, J Esteve, S Brunet, MA Sanz, P Fernández-Abellán, ...
Leukemia & lymphoma 44 (9), 1541-1543, 2003
372003
Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk‐adapted protocols
C Motlló, JM Ribera, M Morgades, I Granada, P Montesinos, ...
Cancer 120 (24), 3958-3964, 2014
302014
Lack of negative impact of Philadelphia chromosome in older patients with acute lymphoblastic leukaemia in the thyrosine kinase inhibitor era: comparison of two prospective …
JM Ribera, O García, P Fernández-Abellán, E Lavilla, MT Bernal, ...
British journal of haematology 159 (4), 485-488, 2012
212012
Evolution of the residual risk of HBV, HCV and HIV transmission through blood transfusion in the Region of Valencia, Spain, during a 15-year period (2003–2017)
C López-Menchero, M Alvarez, P Fernández, M Guzmán, ...
Blood transfusion 17 (6), 418, 2019
202019
Single-agent daratumumab in patients with relapsed and refractory multiple myeloma requiring dialysis: results of a Spanish retrospective, multicentre study
MJ Cejalvo, M Legarda, E Abella, E Cabezudo, C Encinas, A García-Feria, ...
British journal of haematology 190 (5), e289-e292, 2020
172020
Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study
JM Sancho, M Morgades, R Arranz, P Fernández-Abellán, G Deben, ...
Medicina clínica 131 (11), 401-405, 2008
152008
Results of compassionate therapy with intrathecal depot liposomal cytarabine in acute myeloid leukemia meningeosis
JM Sancho, G Deben, A Parker, JL Piñana, S Bolam, E Sánchez-García, ...
International journal of hematology 86, 33-36, 2007
142007
Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Baseline Risk Factors and Minimal Residual Disease (MRD …
JM Ribera, A Oriol, M Morgades, MA Sanz, P Montesinos, J Sarra, ...
Blood 114 (22), 322, 2009
132009
Resistance to empirical β-lactams recommended in febrile neutropenia guidelines in Gram-negative bacilli bloodstream infections in Spain: a multicentre study
M Chumbita, P Puerta-Alcalde, L Yáñez, MA Cuesta, A Chinea, ...
Journal of Antimicrobial Chemotherapy 77 (7), 2017-2023, 2022
62022
Clinical experience using intrathecal liposomal cytarabine to manage neoplastic meningitis in three patients with acute promyelocytic leukemia
RF Duarte, M Arnan, I Sánchez-Ortega, MPQ de Llano, PF Abellán
Leukemia Research 7 (35), e128-e130, 2011
52011
The system can't perform the operation now. Try again later.
Articles 1–20